SOUTHWELL DAVID P

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$787,113.49
Insider Sells Quantity
13
Insider Sells Sum
$9.09M

Insider Activity of SOUTHWELL DAVID P

According to the SEC Form 4 filings, SOUTHWELL DAVID P, being in a position of

  1. director at Rocket Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 80000 shares for $1.95M,
    over all time since 2017-01-06, has bought 60000 shares for $105,000, and sold 273000 shares for $4.87M.

The largest purchase of all time was on 2010-12-06 and amounted to 12100 shares of First Eagle Alternative Capital BDC, Inc. for $157,277.

The largest sale of all time was on 2024-04-12 and amounted to 70000 shares of Rocket Pharmaceuticals, Inc. for $1.71M.

Biography of SOUTHWELL DAVID P

No biography is available at this moment.

2024-04-15SaleRocket Pharmaceuticals, Inc.
RCKT
director
10,000
0.0111%
$24.05$240,520-18.16%
2024-04-12SaleRocket Pharmaceuticals, Inc.
RCKT
director
70,000
0.0779%
$24.36$1.71M-18.6%
2023-04-17SalePTC Therapeutics, Inc.
PTCT
director
11,429
0.0153%
$51.03$583,187-44.1%
2023-04-17SalePTC Therapeutics, Inc.
PTCT
director
6,241
0.0083%
$50.69$316,348-44.1%
2023-03-31SalePTC Therapeutics, Inc.
PTCT
director
2,571
0.0036%
$50.05$128,672-38.17%
2023-03-27SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.0134%
$45.10$450,956-32.93%
2022-05-18PurchaseTScan Therapeutics, Inc.
TCRX
Chief Executive Officer
25,000
0.0353%
$3.59$89,821-21.23%
2021-09-08PurchaseTScan Therapeutics, Inc.
TCRX
Chief Executive Officer
11,000
0.0377%
$8.73$96,066-53.27%
2020-10-16SalePTC Therapeutics, Inc.
PTCT
director
27,000
0.04%
$51.54$1.39M-8.93%
2018-12-13SaleRocket Pharmaceuticals, Inc.
RCKT
director
77,536
0.1994%
$15.19$1.18M+0.33%
2018-12-07SaleRocket Pharmaceuticals, Inc.
RCKT
director
9,846
0.0256%
$14.91$146,804+3.3%
2018-12-06SaleRocket Pharmaceuticals, Inc.
RCKT
director
105,618
0.2689%
$15.15$1.6M-0.66%
2017-01-06PurchaseRocket Pharmaceuticals, Inc.
RCKT
President and CEO
60,000
0.2289%
$1.75$105,000+4.41%
2015-07-06SalePTC Therapeutics, Inc.
PTCT
director
23,604
0.0695%
$47.52$1.12M-43.94%
2015-03-23SalePTC Therapeutics, Inc.
PTCT
director
2,317
0.007%
$69.04$159,957-49.84%
2014-03-21SalePTC Therapeutics, Inc.
PTCT
director
2,317
0.0094%
$30.93$71,666+17.64%
2010-12-06PurchaseFirst Eagle Alternative Capital BDC, Inc.
FCRX
director
12,100
0.0219%
$13.00$157,277
2010-11-24PurchaseFirst Eagle Alternative Capital BDC, Inc.
FCRX
director
200
0.0004%
$12.84$2,568
2010-11-23PurchaseFirst Eagle Alternative Capital BDC, Inc.
FCRX
director
100
0.0002%
$12.83$1,283
2010-11-22PurchaseFirst Eagle Alternative Capital BDC, Inc.
FCRX
director
101
0.0002%
$12.84$1,296
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.